Registered report: Diverse somatic mutation patterns and pathway alterations in human cancers
- PMID: 26894955
- PMCID: PMC4769161
- DOI: 10.7554/eLife.11566
Registered report: Diverse somatic mutation patterns and pathway alterations in human cancers
Abstract
The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012, were selected on the basis of citations and Altmetric scores (Errington et al., 2014). This Registered Report describes the proposed replication plan of key experiments from "Diverse somatic mutation patterns and pathway alterations in human cancers" by Kan and colleagues published in Nature in 2010 (Kan et al., 2010). The experiments to be replicated are those reported in Figures 3D-F and 4C-F. Kan and colleagues utilized mismatch repair detection (MRD) technology to identify somatic mutations in primary human tumor samples and identified a previously uncharacterized arginine 243 to histidine (R243H) mutation in the G-protein α subunit GNAO1 in breast carcinoma tissue. In Figures 3D-F, Kan and colleagues demonstrated that stable expression of mutant GNAO1(R243D) conferred a significant growth advantage in human mammary epithelial cells, confirming the oncogenic potential of this mutation. Similarly, expression of variants with somatic mutations in MAP2K4, a JNK pathway kinase (shown in Figures 4C-E) resulted in a significant increase in anchorage-independent growth. Interestingly, these mutants exhibited reduced kinase activity compared to wild type MAP2K4, indicating these mutations impose a dominant-negative influence to promote growth (Figure 4F). The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange and the results of the replications will be published in eLife.
Keywords: MAP kinase kinase 4; human; human biology; medicine; methodology; reproducibility project: cancer biology; somatic mutation.
Conflict of interest statement
VS the experiments presented in this manuscript will be conducted at Applied Biological Materials, which is a Science Exchange lab.
LY the experiments presented in this manuscript will be conducted at Applied Biological Materials, which is a Science Exchange lab.
The other authors declare that no competing interests exist.
RP:CB employed by and holds shares in Science Exchange Inc.
Similar articles
-
Registered Report: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.Elife. 2016 Mar 21;5:e11414. doi: 10.7554/eLife.11414. Elife. 2016. PMID: 26999821 Free PMC article.
-
Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.Elife. 2016 Feb 16;5:e09976. doi: 10.7554/eLife.09976. Elife. 2016. PMID: 26882073 Free PMC article.
-
Registered report: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia.Elife. 2015 Sep 1;4:e08997. doi: 10.7554/eLife.08997. Elife. 2015. PMID: 26327698 Free PMC article.
-
Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.Evid Rep Technol Assess (Full Rep). 2007 May;(150):1-180. Evid Rep Technol Assess (Full Rep). 2007. PMID: 17764220 Free PMC article. Review.
-
The Effect of Replications on Citation Patterns: Evidence From a Large-Scale Reproducibility Project.Psychol Sci. 2021 Oct;32(10):1537-1548. doi: 10.1177/09567976211005767. Epub 2021 Sep 17. Psychol Sci. 2021. PMID: 34534028 Review.
Cited by
-
Challenges for assessing replicability in preclinical cancer biology.Elife. 2021 Dec 7;10:e67995. doi: 10.7554/eLife.67995. Elife. 2021. PMID: 34874008 Free PMC article.
-
Experiments from unfinished Registered Reports in the Reproducibility Project: Cancer Biology.Elife. 2021 Dec 7;10:e73430. doi: 10.7554/eLife.73430. Elife. 2021. PMID: 34874009 Free PMC article.
References
-
- Ahn Y-H, Yang Y, Gibbons DL, Creighton CJ, Yang F, Wistuba II, Lin W, Thilaganathan N, Alvarez CA, Roybal J, Goldsmith EJ, Tournier C, Kurie JM. Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor 2 expression. Molecular and Cellular Biology. 2011;31:4270–4285. doi: 10.1128/MCB.05562-11. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
